| Dr Ralph Chandler Harvey, MD | |
|
2400 Round Rock Ave, Round Rock, TX 78681-4004 | |
| (512) 341-1000 | |
| Not Available |
| Full Name | Dr Ralph Chandler Harvey |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 2400 Round Rock Ave, Round Rock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902018450 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 118019 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Regional Health Care System | Wichita falls, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wichita Falls Anesthesia Pllc | 7012259260 | 33 |
News Archive
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
With the new SPIDER Smart Photo-Imaging Measurement Technology, orthotists and patients will benefit from a seamless electronic fitting and ordering process for one of Ottobock's most popular orthotic solutions: the FreeWalk.
Merck & Co., Inc. has provided an update on the status of credit facilities that will be used to finance its recently announced agreement to merge with Schering-Plough Corporation.
Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.
GI Dynamics, Inc., a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011.
› Verified 9 days ago
| Entity Name | Falls Town Anesthesia Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447685466 PECOS PAC ID: 1759517238 Enrollment ID: O20131112001671 |
News Archive
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
With the new SPIDER Smart Photo-Imaging Measurement Technology, orthotists and patients will benefit from a seamless electronic fitting and ordering process for one of Ottobock's most popular orthotic solutions: the FreeWalk.
Merck & Co., Inc. has provided an update on the status of credit facilities that will be used to finance its recently announced agreement to merge with Schering-Plough Corporation.
Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.
GI Dynamics, Inc., a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011.
› Verified 9 days ago
| Entity Name | Wichita Falls Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639636210 PECOS PAC ID: 7012259260 Enrollment ID: O20190508002236 |
News Archive
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
With the new SPIDER Smart Photo-Imaging Measurement Technology, orthotists and patients will benefit from a seamless electronic fitting and ordering process for one of Ottobock's most popular orthotic solutions: the FreeWalk.
Merck & Co., Inc. has provided an update on the status of credit facilities that will be used to finance its recently announced agreement to merge with Schering-Plough Corporation.
Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.
GI Dynamics, Inc., a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ralph Chandler Harvey, MD 1719 Meadowbrook Dr, Winston Salem, NC 27104-1117 Ph: (336) 721-1045 | Dr Ralph Chandler Harvey, MD 2400 Round Rock Ave, Round Rock, TX 78681-4004 Ph: (512) 341-1000 |
News Archive
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
With the new SPIDER Smart Photo-Imaging Measurement Technology, orthotists and patients will benefit from a seamless electronic fitting and ordering process for one of Ottobock's most popular orthotic solutions: the FreeWalk.
Merck & Co., Inc. has provided an update on the status of credit facilities that will be used to finance its recently announced agreement to merge with Schering-Plough Corporation.
Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.
GI Dynamics, Inc., a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011.
› Verified 9 days ago
Robert P. Wills, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2000 S Mays St Ste 201, Round Rock, TX 78664 Phone: 512-244-4272 Fax: 512-244-2895 | |
Jason D Parker, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 | |
Dr. Jay L. York, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 University Blvd, Round Rock, TX 78665 Phone: 512-509-9289 | |
Dr. Edward Wayne Petrik, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3004 Live Oak St, Round Rock, TX 78681 Phone: 737-293-0000 | |
Asim S Aijaz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 S Mays St Ste 201, Round Rock, TX 78664 Phone: 512-244-4272 Fax: 512-244-2895 | |
Jake P Huntzinger, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 2000 S Mays St Ste 201, Round Rock, TX 78664 Phone: 512-244-4272 Fax: 512-244-2895 | |
Joyce L Onwere, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 |